SEC Form 4 · accession 0001415889-18-000338
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel B Soland
Director
Period of report
Mar 1, 2018
Accepted (ET)
Mar 2, 2018 · 6:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2018 | P | 2,000 | $23.02 | A | 2,000 | D | |
| Common Stock | Mar 1, 2018 | P | 3,000 | $24.09 | A | 5,000 | D | |
| Common Stock | Mar 1, 2018 | P | 2,000 | $24.52 | A | 7,000 | D | |
| Common Stock | Mar 2, 2018 | P | 3,000 | $22.52 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.